ProductsBack/InVivoSIM anti-human CD20 (Rituximab Biosimilar)

InVivoSIM anti-human CD20 (Rituximab Biosimilar)

Name: InVivoSIM anti-human CD20 (Rituximab Biosimilar)
SKU: SIM0008_B56
Availability: BackOrder

SIM0008

ApplicationsFunctional Assay, Flow Cytometry, Western Blot, ELISA, Other Application

Product group Antibodies

Overview

Supplier
Bio X Cell
Product Name
InVivoSIM anti-human CD20 (Rituximab Biosimilar)
Delivery Days Customer
7
Applications
Functional Assay, Flow Cytometry, Western Blot, ELISA, Other Application
Certification
Research Use Only
Clonality
Monoclonal
Clone ID
Rituximab
Concentration
4-11 mg/ml
Estimated Purity
>95%
Host
Human
Isotype
IgG1
Storage Instruction
2°C to 8°C
UNSPSC
12352203

Berjis A, Muthumani D, Aguilar OA, et al. Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation. Nat Commun. 2024,15(1):3937. doi: 10.1038/s41467-024-47574-0
Read this paper
Jarvi NL, Balu-Iyer SV. A mechanistic marker-based screening tool to predict clinical immunogenicity of biologics. Commun Med (Lond). 2023,3(1):174. doi: 10.1038/s43856-023-00413-7
Read this paper
Lee DH, Ahn H, Sim HI, et al. A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity. J Exp Clin Cancer Res. 2023,42(1):272. doi: 10.1186/s13046-023-02840-9
Read this paper
Müller T, Tasser C, Tesar M, et al. Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method. MAbs. 2023,15(1):2245519. doi: 10.1080/19420862.2023.2245519
Read this paper
Curreri AM, Kim J, Dunne M, et al. Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics. Adv Sci (Weinh). 2023,10(7):e2205389. doi: 10.1002/advs.202205389
Read this paper